text: Yo, check it out, I got a study to report,
  About serum glycated aplipoprotein B, you ought to take note.
  Using protease, we got an assay method in place,
  Correlating G-apo B levels with other serum parameters, no time to waste.
  
  In diabetics, we found a clinical significance,
  For G-apo B, it's a marker of experience.
  Significantly correlated with glyco-albumin and glycohemoglobin too,
  But no difference with total cholesterol, lipids ain't in the crew.
  
  Type 2 diabetics with hyperlipidemia or without,
  Had significantly higher G-apo B, there's no doubt.
  Compared them both, no significant disparity,
  But nodular and disrupted LDL showed higher G-apo B, fairly.
  
  In fact, nodular LDL had levels off the charts,
  Higher than disrupted LDL, setting it apart.
  G-apo B's an independent risk marker, no joke,
  For diabetes hyperlipidemia and atherogenesis, watch it provoke.